Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal Add-on in Mixed Bipolar Disorder
NCT00223509Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Aug 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lamotrigine in bipolar disorder (BD), sponsored by UT Health San Antonio. Primary endpoints: Proportion of patients achieving a 50% reduction of depressive symptoms at 10 weeks, Montgomery-Asberg Depression Rating Scale at 12 weeks and 1 more. Started Aug 2005; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00223509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223509.